BerandaAMRN • NASDAQ
add
Amarin Corporation PLC
$14,03
Sebelum Jam Perdagangan Normal:(2,00%)-0,28
$13,75
Tutup: 8 Jan, 04.09.40 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$13,69
Rentang hari
$13,72 - $14,17
Rentang tahun
$7,08 - $20,90
Kapitalisasi pasar
291,72 jt USD
Volume Rata-Rata
86,09 rb
Rasio P/E
-
Hasil dividen
-
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 49,67 jt | 17,43% |
Biaya operasional | 23,90 jt | -42,32% |
Penghasilan bersih | -7,74 jt | 69,21% |
Margin laba bersih | -15,58 | 73,78% |
Penghasilan per saham | 0,19 | 119,00% |
EBITDA | -830,00 rb | 96,60% |
Tarif pajak efektif | 4,65% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 286,59 jt | -6,26% |
Total aset | 659,81 jt | -12,10% |
Total liabilitas | 200,92 jt | -8,36% |
Total ekuitas | 458,89 jt | — |
Saham yang beredar | 20,79 jt | — |
Harga terhadap nilai buku | 0,62 | — |
Tingkat pengembalian aset | -0,64% | — |
Tingkat pengembalian modal | -0,90% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -7,74 jt | 69,21% |
Kas dari operasi | -12,70 jt | -438,01% |
Kas dari investasi | -12,13 jt | 78,55% |
Kas dari pembiayaan | -248,00 rb | -264,71% |
Perubahan kas bersih | -25,07 jt | 57,49% |
Arus kas bebas | -35,27 jt | -370,37% |
Tentang
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Didirikan
1 Mar 1989
Kantor pusat
Situs
Karyawan
275
